Discovery of record-length python in Sulawesi highlights threats and conservation efforts for giant snakes in Indonesia.

Recursion’s FAP drug shows durable polyp reduction in phase 1b/2 trial ...

We list the best Python online courses, to make it simple and easy for coders of various levels to evolve their skills with accessible tutorials. Python is one of the most popular high-level, ...

Greater availability of real-world data and real-world evidence is rapidly changing the landscape of drug development. At Reuters Pharma USA, Hemanth Kanakamedala, vice president of decision science ...

In-N-Out said this week it is relocating its headquarters back to Baldwin Park in Los Angeles County to "bring its West Coast headquarters team back together under one roof." With that consolidation, ...

The artificial intelligence (AI) revolution continues to tout developing drugs faster and at lower cost, but are we there yet? On October 2nd, the FDA cleared an investigational new drug (IND) ...

Sept 3 (Reuters) - Nvidia-backed Recursion Pharmaceuticals (RXRX.O), opens new tab said on Tuesday its experimental drug to treat a rare brain-related condition was safe and tolerable in a mid-stage ...

Recursion has stumbled through an early test of its tech-enabled approach to drug discovery, reporting a hit on its phase 2 primary endpoint of safety and tolerability but failing to wow on the ...

For years, drug developers that apply artificial intelligence (AI) have touted the benefits of the technology—the prospect of speedier development of new treatments at lower cost, thus reducing the ...

(Reuters) -Nvidia-backed Recursion Pharmaceuticals said on Tuesday its experimental drug to treat a rare brain-related condition was safe and tolerable in a mid-stage study, but showed mixed results ...